IQVIA CEO Ari Bousbib to Speak at Baird Global Healthcare Conference on September 14, 2022

Rhea-AI Summary

IQVIA Holdings Inc. (NYSE:IQV) will have its chairman and CEO, Ari Bousbib, speak at the Baird 2022 Global Healthcare Conference in New York City on September 14, 2022, at 2:35 p.m. ET. Investors can access a live audio webcast via the IQVIA Investor Relations website, with a replay available later. IQVIA is a global leader in analytics and clinical research services, enhancing healthcare through innovative insights and technology with a workforce of approximately 82,000 across over 100 countries.

RESEARCH TRIANGLE PARK, N.C.--(BUSINESS WIRE)-- IQVIA Holdings Inc. (“IQVIA”) (NYSE:IQV), announced today that Ari Bousbib, chairman and chief executive officer, will speak at the Baird 2022 Global Healthcare Conference in New York City on Wednesday, September 14, 2022 at 2:35 p.m. ET.

A live audio webcast of the presentation will be available on the IQVIA Investor Relations website at http://ir.iqvia.com. A replay of the webcast will be available later that day.

About IQVIA

IQVIA (NYSE:IQV) is a leading global provider of advanced analytics, technology solutions, and clinical research services to the life sciences industry. IQVIA creates intelligent connections across all aspects of healthcare through its analytics, transformative technology, big data resources and extensive domain expertise. IQVIA Connected Intelligence™ delivers powerful insights with speed and agility — enabling customers to accelerate the clinical development and commercialization of innovative medical treatments that improve healthcare outcomes for patients. With approximately 82,000 employees, IQVIA conducts operations in more than 100 countries.

IQVIA is a global leader in protecting individual patient privacy. The company uses a wide variety of privacy-enhancing technologies and safeguards to protect individual privacy while generating and analyzing information on a scale that helps healthcare stakeholders identify disease patterns and correlate with the precise treatment path and therapy needed for better outcomes. IQVIA’s insights and execution capabilities help biotech, medical device and pharmaceutical companies, medical researchers, government agencies, payers and other healthcare stakeholders tap into a deeper understanding of diseases, human behaviors and scientific advances, in an effort to advance their path toward cures. To learn more, visit www.iqvia.com.

IQVIAFIN

View source version on businesswire.com: https://www.businesswire.com/news/home/20220902005014/en/

Nick Childs, IQVIA Investor Relations (nicholas.childs@iqvia.com)

+1.973.316.3828

Trent Brown, IQVIA Media Relations (trent.brown@iqvia.com)

+1.919.780.3221

Source: IQVIA

FAQ

What date will IQVIA speak at the Baird 2022 Global Healthcare Conference?

IQVIA will speak at the Baird 2022 Global Healthcare Conference on September 14, 2022.

Who will represent IQVIA at the Baird 2022 Global Healthcare Conference?

Ari Bousbib, the chairman and CEO of IQVIA, will represent the company at the conference.

Where is the Baird 2022 Global Healthcare Conference taking place?

The Baird 2022 Global Healthcare Conference will take place in New York City.

What time is IQVIA's presentation at the conference?

IQVIA's presentation is scheduled for 2:35 p.m. ET.

How can I access the webcast of IQVIA's presentation?

A live audio webcast will be available on the IQVIA Investor Relations website.

Will there be a replay of IQVIA's conference presentation?

Yes, a replay of the webcast will be available later on the same day.